<unk>  is a Antineoplastic Agents that is FDA approved for the treatment of The treatment of patients with lung cancer
Should not be given to patients who are pregnant or are trying to get pregnant
This medication is only to be used after confirming the cancer has a ALK gene marker
The doctor will test for that gene. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include Edema, Peripheral Neuropathy, Cognitive Effects, Dyspnea (shortness of breath), fatigue, weight gain, arthralgia, mood effects, diarrhea.
Lorlatinib
Neratinib
Fostamatinib
Brigatinib
Lenvatinib
Dasatinib
Afatinib
Erdafitinib